research use only

R59949

Cat.No.E0082

R59949, a diacylglycerol kinase (DGK) inhibitor with an IC50 of 300 nM, inhibits inducible nitric oxide production through decreasing transplasmalemmal L-arginine uptake in vascular smooth muscle cells. This compound strongly inhibits type I DGK a and γ, and moderately attenuates type II DGK θ and κ.
R59949 Chemical Structure

Chemical Structure

Molecular Weight: 489.58

Quality Control

Batch: E008201 DMSO]98 mg/mL]false]Ethanol]2 mg/mL]false]Water]Insoluble]false Purity: 99.24%
99.24

Chemical Information, Storage & Stability

Molecular Weight 489.58 Formula

C28H25F2N3OS

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 120166-69-0 -- Storage of Stock Solutions

Synonyms N/A Smiles FC1=CC=C(C=C1)C(=C2CCN(CCN3C(=S)NC4=CC=CC=C4C3=O)CC2)C5=CC=C(F)C=C5

Solubility

In vitro
Batch:

DMSO : 98 mg/mL (200.17 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 2 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Targets/IC50/Ki
DKG [1]
0.3 μM
In vitro

R59949 is a pan diacylglycerol kinase (DGK) inhibitor, which inhibits inducible NO production through decreasing transplasmalemmal L-arginine uptake in rat aortic smooth muscle cells (RASMCs).[1]

In vivo

R59949 upregulates the expression of PHD-2, also downregulates HIF-1α and vascular endothelial growth factor (VEGF) in the retina of oxygen-induced retinopathy (OIR) mice, suggesting a potential possibility that this compound suppresses retinal neovascular pathophysiology via PHD2/HIF-1α/VEGF pathway.[2]

References

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.